Difference between revisions of "Part:BBa K364301"
(One intermediate revision by the same user not shown) | |||
Line 8: | Line 8: | ||
member and a critical mediator of p53-dependent and -independent apoptosis induced by a wide | member and a critical mediator of p53-dependent and -independent apoptosis induced by a wide | ||
variety of stimuli, including genotoxic stress, deregulated oncogene expression, toxins, altered | variety of stimuli, including genotoxic stress, deregulated oncogene expression, toxins, altered | ||
− | redox status, growth factor/cytokine withdrawal and infection. | + | redox status, growth factor/cytokine withdrawal and infection.PUMA transduces death signals primarily to the mitochondria, where it acts indirectly on the Bcl-2 family members Bax and/or Bak by relieving the inhibition imposed by antiapoptotic members. It directly binds and antagonizes all known antiapoptotic Bcl-2 family members to |
− | + | ||
− | PUMA transduces death signals primarily to the mitochondria, where it acts indirectly on the | + | |
− | Bcl-2 family members Bax and/or Bak by relieving the inhibition imposed by antiapoptotic | + | |
− | members. It directly binds and antagonizes all known antiapoptotic Bcl-2 family members to | + | |
induce mitochondrial dysfunction and caspase activation. PUMA ablation or inhibition leads to | induce mitochondrial dysfunction and caspase activation. PUMA ablation or inhibition leads to | ||
apoptosis deficiency underlying increased risks for cancer development and therapeutic resistance. | apoptosis deficiency underlying increased risks for cancer development and therapeutic resistance. | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<!-- --> | <!-- --> |
Latest revision as of 10:15, 13 August 2010
hPUMA
PUMA
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]